Scarica l'app Stockscreener
2.08
1.89%
-0.04
Dopo l'orario di chiusura:
2.04
-0.04
-1.92%
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché JAGX Giù?
Forum
Previsione
Frazionamento azionario
Jaguar Health Inc Borsa (JAGX) Ultime notizie
Why Jaguar Health Inc. stock remains a top recommendationJuly 2025 Gainers & Reliable Entry Point Trade Alerts - Trung tâm Dự báo KTTV quốc gia
Real time social sentiment graph for Jaguar Health Inc.Earnings Summary Report & Free Safe Capital Growth Stock Tips - newser.com
Why Jaguar Health Inc. stock attracts high net worth investorsJuly 2025 Price Swings & Accurate Entry/Exit Alerts - Trung tâm Dự báo KTTV quốc gia
Is Jaguar Health Inc. stock a buy before product launchesVolume Spike & Free Technical Pattern Based Buy Signals - Trung tâm Dự báo KTTV quốc gia
What analysts say about Jaguar Health Inc stockSector Performance Drivers & Fast Growing Trading Plans - earlytimes.in
Will Jaguar Health Inc. stock pay special dividends2025 Short Interest & Real-Time Chart Pattern Alerts - newser.com
Jaguar Health Presenting at September 8-10 H.C. Wainwright Annual Global Investment Conference to Provide Updates on Near-Term Catalysts - Gainesville Sun
Jaguar Health Inc (HAM:1JA0)Valuation Measures & Financial Statistics - GuruFocus
Is now a turning point for Jaguar Health Inc.Earnings Miss & Verified Trade Idea Suggestions - newser.com
Jaguar Health Reports Approval of All Proposals at August 2025 Annual Meeting of Stockholders - The Commercial Appeal
Jaguar Health (HAM:1JA0) OCF Yield % : -360.65 (As of Oct. 14, 2025) - GuruFocus
FDA-Authorized Expanded Access Programs Utilizing Jaguar Health's Novel Crofelemer Powder for Oral Solution to Treat Two Pediatric Intestinal Failure Patients with Microvillus Inclusion Disease - Worcester Telegram
Evaluating Jaguar Health Inc. with trendline analysis2025 Market Outlook & Daily Stock Momentum Reports - newser.com
Analyzing Jaguar Health Inc. with risk reward ratio chartsJuly 2025 Reactions & Consistent Income Trade Recommendations - newser.com
Price action breakdown for Jaguar Health Inc.Quarterly Profit Summary & Reliable Intraday Trade Alerts - newser.com
Jaguar Health Presenting September 25 at Emerging Growth Conference and September 30 at Lytham Partners Fall 2025 Conference to Provide Updates on Near-Term Catalysts - Lansing State Journal
Jaguar Health Submits Orphan Drug Designation Application to FDA for Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Patients with Breast Cancer with Metastasis Identified by FDA as a Distinct Condition - Shreveport Times
Jaguar Health, Inc.Common Stock (NQ: JAGX - FinancialContent
JAGX completes $1M private equity offering under Rule 506(b) - Stock Titan
Using fundamentals and technicals on Jaguar Health Inc.Exit Point & High Win Rate Trade Alerts - newser.com
Chart based analysis of Jaguar Health Inc. trendsQuarterly Trade Review & Stock Market Timing Techniques - newser.com
Published on: 2025-10-10 04:56:36 - newser.com
What machine learning models say about Jaguar Health Inc.July 2025 Trade Ideas & AI Powered Market Entry Ideas - newser.com
Momentum divergence signals in Jaguar Health Inc. chartWatch List & Free Verified High Yield Trade Plans - newser.com
FDA Approves Renewal of Canalevia-CA1, Jaguar Health’s Drug for Chemotherapy-Induced Diarrhea in Dogs - ACCESS Newswire
How to build a custom watchlist for Jaguar Health Inc.New Guidance & Long-Term Safe Investment Plans - newser.com
Tools to assess Jaguar Health Inc.’s risk profile2025 Bull vs Bear & Growth Focused Entry Point Reports - newser.com
Jaguar Health registers 2.62M shares for resale following private placements - MSN
1.84%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):